A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
about
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive studyNevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected PatientsQuantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active TuberculosisHair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingUsing the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled.Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.Isoniazid hair concentrations in children with tuberculosis: a proof of concept studyCYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenSafe Treatment of Seizures in the Setting of HIV/AIDS.Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United StatesShort communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings.Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda.Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapineCommon clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV.Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis.Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring.Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.Distinctiveness of the Roma population within CYP2B6 worldwide variation.Development and Validation of an Assay to Analyze Atazanavir in Human Hair Via Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).A validated liquid chromatography tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from HIV-infected patients.A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair.Cohort Profile: The Women's Interagency HIV Study (WIHS).Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study.
P2860
Q28538457-C809C476-4389-4AA0-ADC7-E55EBDCD7F50Q28541365-BA583D8A-0A4F-406A-A8CE-6034A8542B77Q28548003-4FC8F644-3B1D-48DB-A2D1-04709FEAF8CFQ28552186-96C81884-20F6-4FA9-9F36-F8D3C598F5EBQ30679524-8D546050-9F63-4DED-85CF-16C07449DD94Q33640486-8275EE62-A3A8-4E80-9450-B235A8155D19Q35114865-7DDDACED-26FC-430E-80EA-55A65ECD4727Q35627832-514F54A3-642E-4757-A5FC-6A3C5E22C369Q35869663-FB5692A3-0A83-48DE-8608-C55F6BFB3776Q36663586-D8DA4BEA-7C13-43C0-A374-2EC6BA852A0EQ36958417-A6316BF0-5738-49DA-B27E-8D9361340128Q36966640-E9710519-B283-42EA-89F7-2345B6220101Q37096562-5F9DE10B-E9A8-43F3-BF53-D77EA1E8120CQ37272859-6C9167DB-E6A0-4737-B5A5-20BF0B30622FQ37460068-BE0D4FBA-303B-46B7-8DFE-F1D8D6B8491FQ37600844-2B6BD2A8-915B-4C2B-94A7-5F1BE63CB1D9Q37613197-E61E9D3F-8788-4C0F-8257-16842EC536DAQ37641171-413CD0D9-8AB7-42D8-86F1-B54E55783482Q40219167-8173DB0F-806F-44B2-872A-1655D62F6843Q41631965-2E3321C6-D084-49F8-A450-EBEDB1B573BEQ46272254-1F880161-3352-4A11-988D-B49157788315Q46679475-1DABFC3D-03A5-4788-A4B8-65E3D0859C1AQ47670434-C837E4B2-11AC-4A28-8146-2315739DE038Q47724822-9BC95DDE-D887-490C-A304-68FA6CEDCE1BQ50052945-CCE589BF-D385-474C-826E-2660F5A1994EQ50120171-0D76EDEB-258F-4268-BC86-707B6AF41B0FQ54229338-FE345057-8E14-4A90-BF1E-73CF44EB24F4Q55311524-87CAD627-EAB1-418B-80CB-C979CB1F6027
P2860
A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@ast
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@en
type
label
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@ast
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@en
prefLabel
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@ast
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@en
P2093
P2860
P356
P1476
A single-nucleotide polymorphi ...... hair among HIV-infected women.
@en
P2093
Bradley Aouizerat
Chenglong Liu
Chengshi Jin
Gerald B Sharp
Jack A Dehovitz
Kathryn Anastos
Mardge Cohen
Monica Gandhi
Peter Bacchetti
Ruth M Greenblatt
P2860
P304
P356
10.1093/INFDIS/JIS508
P407
P577
2012-08-20T00:00:00Z